Global Cord Blood Corpora... (CO)
NYSE: CO
· Real-Time Price · USD
2.99
0.77 (34.68%)
At close: Jun 09, 2023, 3:43 PM
Global Cord Blood Income Statement
Financials in CNY. Fiscal
year is
April - March.
| Fiscal Year | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jul 5, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Revenue | 297.21M | 297.21M | 317.2M | 313.67M | 315.17M | 302.32M | 290.8M | 285.61M | 280.91M |
Cost of Revenue | 41.98M | 41.98M | 47.28M | 46.21M | 47.84M | 45.91M | 44.88M | 44.7M | 43.46M |
Gross Profit | 255.23M | 255.23M | 269.92M | 267.46M | 267.33M | 256.41M | 245.92M | 240.91M | 237.45M |
Operating Income | 142.14M | 142.14M | 149.72M | 160.45M | 156.56M | 148.24M | 123.96M | 139.16M | 133.51M |
Interest Income | n/a | 8.43M | 8M | 7.99M | 8.19M | 8.13M | 7.19M | 8.81M | 6.77M |
Pretax Income | 140.06M | 140.06M | 159.13M | 156.39M | 172.25M | 154.72M | 139.38M | 156.21M | 160.45M |
Net Income | 106.8M | 104.72M | 134.19M | 125.74M | 136.42M | 127.73M | 116.57M | 131.43M | 132.51M |
Selling & General & Admin | -10.65M | 108.31M | 113.36M | 101.44M | 105.68M | 102.68M | 112.98M | 96.8M | 99.6M |
Research & Development | -4.78M | 4.78M | 6.84M | 5.57M | 5.1M | 5.49M | 8.98M | 4.95M | 4.34M |
Other Expenses | n/a | n/a | n/a | 583K | 639K | n/a | n/a | n/a | n/a |
Operating Expenses | -15.43M | 113.09M | 120.2M | 107.01M | 110.78M | 108.17M | 121.96M | 101.75M | 103.94M |
Interest Expense | 2.07M | 4.16M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | -59.48M | 59.48M | 65.92M | 56.92M | 59.4M | 59.51M | 68.99M | 54.12M | 55.06M |
Cost & Expenses | 26.55M | 155.07M | 167.48M | 153.22M | 158.62M | 154.08M | 166.84M | 146.45M | 147.4M |
Income Tax Expense | 33.27M | 33.27M | 23.57M | 28.25M | 33.27M | 24.41M | 21.22M | 22.89M | 26.02M |
Shares Outstanding (Basic) | 121.76M | 121.76M | 120.89M | 122.07M | 121.8M | 121.65M | 121.43M | 121.7M | 121.57M |
Shares Outstanding (Diluted) | 121.76M | 121.76M | 120.89M | 122.07M | 121.8M | 121.65M | 121.43M | 121.7M | 121.57M |
EPS (Basic) | 0.88 | 0.86 | 1.12 | 1.03 | 1.12 | 1.05 | 0.96 | 1.08 | 1.09 |
EPS (Diluted) | 0.88 | 0.86 | 1.12 | 1.03 | 1.12 | 1.05 | 0.96 | 1.08 | 1.09 |
EBITDA | 142.14M | 156.36M | 157.76M | 153.99M | 169.69M | 152.15M | 137.79M | 154.32M | 158.53M |
EBIT | 142.14M | 144.22M | 151.08M | 160.45M | 156.56M | 148.24M | 123.96M | 139.16M | 133.51M |
Depreciation & Amortization | 41.58K | 14.22M | 8.04M | -6.46M | 13.13M | 3.91M | 13.83M | 15.16M | 25.02M |